Clinical Trial Update: Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of oral senicapoc for exercise-induced asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Asthma

Drugs mentioned

• Senicapoc (senicapoc)

Snippet

Sponsor: Icagen | Conditions: Exercise Induced Asthma | Phase 2 | Status: COMPLETED